Literature DB >> 28930368

The importance of polymorphic variants of collagen 1A2 gene (COL1A2) in the development of osteopenia and osteoporosis in postmenopausal women.

Marian Majchrzycki, Joanna Bartkowiak-Wieczorek, Anna Bogacz, Joanna Szyfter-Harris, Hubert Wolski, Andrzej Klejewski, Maciej Goch, Krzysztof Drews, Magdalena Barlik1, Marcin Ożarowski, Adam Kamiński, Agnieszka Gryszczyńska, Agnieszka Seremak-Mrozikiewicz.   

Abstract

OBJECTIVES: Collagen type I plays an important role in the bone matrix and is encoded by COL1A2 (collagen type I alpha 2) gene that may be a potential candidate for osteoporotic fracture. The aim of this study is to determine whether EcoRI, Del38 and PvuII polymorphisms of COL1A2 are associated with the development of osteoporosis and osteopenia in post-menopausal Polish women. Moreover, analysis of relationship between frequency of COL1A2 gene polymorphic variants and clinical parameters of bone turnover and degree of osteoporosis was performed.
MATERIAL AND METHODS: The study group comprised of women with osteoporosis (n = 90), osteopenia (n = 56) and healthy individuals (n = 56). The EcoRI, Del38 and PvuII polymorphisms in COL1A2 gene were detected by PCR-RFLP method.
RESULTS: In women with osteoporosis the TT genotype of EcoRI polymorphism had the lowest Z-score value compared to other genotypes (p = 0.034). In case of Del28 polymorphism, there was a statistically significant correlation between lower BMI values and the DD genotype in women with osteopenia (p = 0.041). There was no statistically significant correlation between polymorphic variants of Del28 polymorphism and clinical parameters of women with osteoporosis. The analysis of PvuII polymorphism showed that in women with osteopenia the CC genotype had the lowest body weight compared to other genotypes (p = 0.039). PvuII polymorphism and clinical parameters in the group of women with osteoporosis had no statistically significant correlations.
CONCLUSIONS: The analyzed COL1A2 polymorphisms seem to be related to osteoporosis development and their particular clinical parameters. Hence, the COL1A2 polymorphism may be a genetic risk factor related to the development of osteoporosis.

Entities:  

Keywords:  COL1A2; genetic marker; osteopenia; osteoporosis; polymorphism

Mesh:

Substances:

Year:  2017        PMID: 28930368     DOI: 10.5603/GP.a2017.0077

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  3 in total

Review 1.  Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases.

Authors:  Lucia Oton-Gonzalez; Chiara Mazziotta; Maria Rosa Iaquinta; Elisa Mazzoni; Riccardo Nocini; Lorenzo Trevisiol; Antonio D'Agostino; Mauro Tognon; John Charles Rotondo; Fernanda Martini
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

2.  Regulation of COL1A2, AKT3 genes, and related signaling pathway in the pathology of congenital talipes equinovarus.

Authors:  Ningqing Wang; Jiangchao Zhang; Haixiang Lv; Zhenjiang Liu
Journal:  Front Pediatr       Date:  2022-07-22       Impact factor: 3.569

3.  Analysis of Molecular Mechanism of Erxian Decoction in Treating Osteoporosis Based on Formula Optimization Model.

Authors:  Lang Yang; Liuyi Fan; Kexin Wang; Yupeng Chen; Lan Liang; Xuemei Qin; Aiping Lu; Peng Cao; Bin Yu; Daogang Guan; Junxiang Peng
Journal:  Oxid Med Cell Longev       Date:  2021-06-18       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.